New drug duo tested in Tough-to-Treat esophageal cancer
NCT ID NCT06753747
Summary
This study is testing whether combining two existing drugs, afatinib and palbociclib, can help control advanced esophageal cancer that has come back or spread after prior treatment. The first part of the trial will find a safe dose, and the second part will see if the combination can shrink tumors in up to 45 patients. The goal is to see if this new approach can offer a new option for people who have run out of standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGUS CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Hospital
RECRUITINGChengdu, Sichuan, 610041, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.